Related references
Note: Only part of the references are listed.m6A RNA methylation: from mechanisms to therapeutic potential
P. Cody He et al.
EMBO JOURNAL (2021)
RNA-binding proteins in human genetic disease
Fatima Gebauer et al.
NATURE REVIEWS GENETICS (2021)
Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer
Huifang Chen et al.
MOLECULAR CANCER (2021)
Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance
Yalan Deng et al.
NATURE COMMUNICATIONS (2021)
Pooled CRISPR screening identifies m6A as a positive regulator of macrophage activation
Jiyu Tong et al.
SCIENCE ADVANCES (2021)
Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade
Stephane Terry et al.
CLINICAL CANCER RESEARCH (2021)
PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance
Neil E. Bhola et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)
How RNA-Binding Proteins Interact with RNA: Molecules and Mechanisms
Meredith Corley et al.
MOLECULAR CELL (2020)
BRD4 inhibition suppresses PD-L1 expression in triple-negative breast cancer
Xin Jing et al.
EXPERIMENTAL CELL RESEARCH (2020)
A Unified Model for the Function of YTHDF Proteins in Regulating m6A-Modified mRNA
Sara Zaccara et al.
CELL (2020)
DENR promotes translation reinitiation via ribosome recycling to drive expression of oncogenes including ATF4
Jonathan Bohlen et al.
NATURE COMMUNICATIONS (2020)
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
T. Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Regulation of PD-L1 Expression by NF-κB in Cancer
Fabrizio Antonangeli et al.
FRONTIERS IN IMMUNOLOGY (2020)
Crystal structure of the C-terminal domain of DENR
Ivan B. Lomakin et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Charting DENR-dependent translation reinitiation uncovers predictive uORF features and links to circadian timekeeping via Clock
Violeta Castelo-Szekely et al.
NUCLEIC ACIDS RESEARCH (2019)
ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression
Feven Tameire et al.
NATURE CELL BIOLOGY (2019)
Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
Adriana Forero et al.
IMMUNITY (2019)
Topoisomerase inhibitors promote cancer cell motility via ROS-mediated activation of JAK2-STAT1-CXCL1 pathway
Jiafei Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation
Florian Perner et al.
CELLS (2019)
Immune cell PD-L1 co-localizes with macrophages and is associated with outcome in PD-1 pathway blockade therapy
Yuting Liu et al.
CLINICAL CANCER RESEARCH (2019)
Mechanisms regulating PD-L1 expression on tumor and immune cells
Shuming Chen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Crystal structure of the DENR-MCT-1 complex revealed zinc-binding site essential for heterodimer formation
Ivan B. Lomakin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu et al.
NATURE MEDICINE (2019)
Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment
Chiara Riganti et al.
ONCOIMMUNOLOGY (2018)
m6A mRNA methylation sustains Treg suppressive functions
Jiyu Tong et al.
CELL RESEARCH (2018)
A brave new world of RNA-binding proteins
Matthias W. Hentze et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Oncogenic JAK2V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
Alessandro Prestipino et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
DENR-MCTS1 heterodimerization and tRNA recruitment are required for translation reinitiation
Yasar Luqman Ahmed et al.
PLOS BIOLOGY (2018)
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
L. Horn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Loss-of-function uORF mutations in human malignancies
Julia Schulz et al.
SCIENTIFIC REPORTS (2018)
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Lionel B. Ivashkiv
NATURE REVIEWS IMMUNOLOGY (2018)
MicroRNA-155 induction via TNF- and IFN- suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells
Daniel Yee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
Vikram R. Juneja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review
Robert Brody et al.
LUNG CANCER (2017)
m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways
Hua-Bing Li et al.
NATURE (2017)
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
Riccardo Mezzadra et al.
NATURE (2017)
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L. Burr et al.
NATURE (2017)
Crystal Structure of the Human Ribosome in Complex with DENR-MCT-1
Ivan B. Lomakin et al.
CELL REPORTS (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
Identification of transcripts with short stuORFs as targets for DENR.MCTS1-dependent translation in human cells
Sibylle Schleich et al.
SCIENTIFIC REPORTS (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
MYC regulates the antitumor immune response through CD47 and PD-L1
Stephanie C. Casey et al.
SCIENCE (2016)
Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis
Laetitia Basset et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Structure-function analysis identifies highly sensitive strigolactone receptors in Striga
Shigeo Toh et al.
SCIENCE (2015)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
N6-methyladenosine-dependent regulation of messenger RNA stability
Xiao Wang et al.
NATURE (2014)
DENR-MCT-1 promotes translation re-initiation downstream of uORFs to control tissue growth
Sibylle Schleich et al.
NATURE (2014)
Ribosomal stress activates eEF2K-eEF2 pathway causing translation elongation inhibition and recruitment of Terminal Oligopyrimidine (TOP) mRNAs on polysomes
Angelo Gismondi et al.
NUCLEIC ACIDS RESEARCH (2014)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Activities of Ligatin and MCT-1/DENR in eukaryotic translation initiation and ribosomal recycling
Maxim A. Skabkin et al.
GENES & DEVELOPMENT (2010)
MicroRNA-513 Regulates B7-H1 Translation and Is Involved in IFN-γ-Induced B7-H1 Expression in Cholangiocytes
Ai-Yu Gong et al.
JOURNAL OF IMMUNOLOGY (2009)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
Share Paper
